The antibiotic was isolated and identified as arenaemycin (T.
Miller and K. Wilson; personal communication).
We report in this communication that arenaemycin and fosfomycin indeed are synergistic in vitro.
The skewed inhibition zones between filter discs on seeded plates indicates that pure arenaemycin and fosfomycin are synergistic (Fig. 1 ).
Quantitative synergy was measured by determining the MICsof fosfomycin and arenaemycin alone and in combined concentrations below the MICs. The data are summarized in Table   1 .
Arenaemycin E is reported to be a selective and strong inhibitor of glycerolaldehyde-3-phosphate dehydrogenase1}.
A proposed site of action of arenaemycin C is on pyruvate kinase2).
Fosfomycin is an inhibitor of phosphoenolpyruvate : UDP-GlcNac-3 -enolpyruvyl transferase and has little or no activity on other phosphoenolpyruvate utilizing enzymes3 Plate containing 5 ml of nutrient agar seeded with Proteus vulgaris MB-838 1 % was incubated at 37°C for 18 hours. Filter disc on left contains fosfomycin 0.25^g and the disc on right contains 1.0 /*g of arenaemycin. Test organisms were grown 20 hours at 37°C with agitation in nutrient broth containing 100^g/ml of glucose-6-phosphate. 0.1 ml of growth was added to tubes containing 9.9 ml of melted cooled nutrient agar supplemented with 100^g/ml of glucose-6-phosphate and containing fosfomycin and arenaemycin alone and in various combinations. Contents of the tubes were vortexed and poured into petri plates. The MICs were determined after 20 hours incubation at 37°C. The FICI10) is the sum of the fractional inhibitory concentrations. The fractional inhibitory concentration of each antibiotic is the amount in combination that produces the MICexpressed as a fraction of the MICof the antibiotic alone. Weaccept an FICI of < 
